Advances in testing
In 2020, Mayo Clinic Laboratories launched more than 100 new tests. Driven by a patient-centered philosophy, our experts, laboratories, and facilities make it possible to develop new tests that transform medicine worldwide.
In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
In January 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
In December 2019, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
In November 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
In October 2019, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
In September 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes. In addition to these new tests, the department also announced several test changes.
In August 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
In July 2019, Mayo Clinic Laboratories announced six new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
In June 2019, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
In May 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
In April 2019, Mayo Clinic Laboratories announced nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
The current diagnostic tools in a pathologist’s arsenal sometimes cannot provide a clear distinction between primary mediastinal large B-cell lymphoma (one of the few lymphomas more common in younger women) and diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma overall.